Correlation Between Regeneron Pharmaceuticals and Chimerix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Chimerix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Chimerix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Chimerix, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Chimerix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Chimerix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Chimerix.

Diversification Opportunities for Regeneron Pharmaceuticals and Chimerix

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Regeneron and Chimerix is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Chimerix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chimerix and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Chimerix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chimerix has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Chimerix go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Chimerix

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Chimerix. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 2.31 times less risky than Chimerix. The stock trades about -0.13 of its potential returns per unit of risk. The Chimerix is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  97.00  in Chimerix on September 1, 2024 and sell it today you would lose (9.00) from holding Chimerix or give up 9.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  Chimerix

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Chimerix 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Chimerix are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Chimerix is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Regeneron Pharmaceuticals and Chimerix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and Chimerix

The main advantage of trading using opposite Regeneron Pharmaceuticals and Chimerix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Chimerix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chimerix will offset losses from the drop in Chimerix's long position.
The idea behind Regeneron Pharmaceuticals and Chimerix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets